Preexposure Prophylaxis Uptake Among Spanish-Speaking Transgender Women: A Randomized Controlled Trial in North and South Carolina, 2019–2022.

GENDER affirming care; HORMONE therapy; EVALUATION of human services programs; CONFIDENCE intervals; TRANS women; HISPANIC Americans; MULTIVARIATE analysis; COMMUNITY health services; PRE-exposure prophylaxis; RANDOMIZED controlled trials; T-test (Statistics); HUMAN services programs; DESCRIPTIVE statistics; CHI-squared test; CONDOMS; DATA analysis software; LOGISTIC regression analysis; STATISTICAL sampling; ODDS ratio

Objectives. To evaluate Chicas Creando Acceso a la Salud (Girls Creating Access to Health; ChiCAS), a Spanish-language, small-group intervention designed to increase preexposure prophylaxis (PrEP) use, consistent condom use, and medically supervised gender-affirming hormone therapy use among Spanish-speaking transgender Latinas who have sex with men. Methods. Participants were 144 HIV-negative Spanish-speaking transgender Latinas, aged 18 to 59 years, living in North and South Carolina. From July 2019 to July 2021, we screened, recruited, and randomized them to the 2-session ChiCAS intervention or the delayed-intervention waitlist control. Participants completed assessments at baseline and 6-month follow-up. Follow-up retention was 94.4%. Results. At follow-up, relative to control participants, ChiCAS participants reported increased PrEP use (adjusted odds ratio [AOR] = 4.64; 95% confidence interval [CI] = 1.57, 13.7; P <.006). However, ChiCAS participants did not report increased use of condoms or medically supervised gender-affirming hormone therapy. ChiCAS participants reported increases in knowledge of HIV (P <.001), sexually transmitted infections (P <.001), and gender-affirming hormone therapy (P =.01); PrEP awareness (P <.001), knowledge (P <.001), and readiness (P <.001); condom use skills (P <.001); and community attachment (P <.001). Conclusions. The ChiCAS intervention was efficacious in increasing PrEP use among Spanish-speaking, transgender Latinas in this trial. (Am J Public Health. 2024;114(1):68–78. https://doi.org/10.2105/AJPH.2023.307444) [ABSTRACT FROM AUTHOR]

Copyright of American Journal of Public Health is the property of American Public Health Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)